Nisa Investment Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.7K Buy
5,773
+4,635
+407% +$24.6K ﹤0.01% 1742
2025
Q1
$10.1K Sell
1,138
-2,767
-71% -$24.5K ﹤0.01% 2091
2024
Q4
$53.5K Sell
3,905
-7,512
-66% -$103K ﹤0.01% 1664
2024
Q3
$313K Buy
11,417
+7,381
+183% +$202K ﹤0.01% 1176
2024
Q2
$98.7K Buy
4,036
+91
+2% +$2.23K ﹤0.01% 1481
2024
Q1
$84.1K Buy
3,945
+60
+2% +$1.28K ﹤0.01% 1518
2023
Q4
$74.4K Buy
3,885
+35
+0.9% +$670 ﹤0.01% 1524
2023
Q3
$61.8K Sell
3,850
-20
-0.5% -$321 ﹤0.01% 1663
2023
Q2
$89.7K Hold
3,870
﹤0.01% 1540
2023
Q1
$90K Sell
3,870
-450
-10% -$10.5K ﹤0.01% 1533
2022
Q4
$63K Buy
4,320
+2
+0% +$29 ﹤0.01% 1706
2022
Q3
$89K Buy
4,318
+58
+1% +$1.2K ﹤0.01% 1542
2022
Q2
$77K Sell
4,260
-2,400
-36% -$43.4K ﹤0.01% 1580
2022
Q1
$168K Sell
6,660
-340
-5% -$8.58K ﹤0.01% 1447
2021
Q4
$184K Buy
7,000
+2,400
+52% +$63.1K ﹤0.01% 1300
2021
Q3
$149 Hold
4,600
﹤0.01% 1529
2021
Q2
$141 Sell
4,600
-1,900
-29% -$58 ﹤0.01% 1545
2021
Q1
$198 Hold
6,500
﹤0.01% 1492
2020
Q4
$129K Buy
6,500
+1,300
+25% +$25.8K ﹤0.01% 1638
2020
Q3
$68K Sell
5,200
-3,369
-39% -$44.1K ﹤0.01% 1672
2020
Q2
$97K Buy
8,569
+549
+7% +$6.22K ﹤0.01% 1456
2020
Q1
$115K Sell
8,020
-2,130
-21% -$30.5K ﹤0.01% 1332
2019
Q4
$276K Buy
10,150
+2,620
+35% +$71.2K ﹤0.01% 1256
2019
Q3
$216K Buy
7,530
+5,210
+225% +$149K ﹤0.01% 1301
2019
Q2
$64K Hold
2,320
﹤0.01% 1481
2019
Q1
$77K Buy
2,320
+2,000
+625% +$66.4K ﹤0.01% 1473
2018
Q4
$9K Hold
320
﹤0.01% 1677
2018
Q3
$15K Buy
320
+20
+7% +$938 ﹤0.01% 1602
2018
Q2
$11K Hold
300
﹤0.01% 1708
2018
Q1
$9K Buy
+300
New +$9K ﹤0.01% 1686
2017
Q1
Sell
-550
Closed -$9K 1886
2016
Q4
$9K Sell
550
-2,150
-80% -$35.2K ﹤0.01% 1818
2016
Q3
$56K Buy
2,700
+500
+23% +$10.4K ﹤0.01% 1394
2016
Q2
$67K Sell
2,200
-300
-12% -$9.14K ﹤0.01% 1367
2016
Q1
$94K Buy
+2,500
New +$94K ﹤0.01% 1342